Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you have been prescribed metronidazole while you are taking semaglutide for weight management, the most important thing to know is that no direct pharmacokinetic interaction between the two medicines has been formally documented in clinical studies. That said, both drugs can independently affect the gut, and the combination deserves a clear-headed look before your next dose. Semaglutide is a prescription-only GLP-1 receptor agonist, available in the UK as Wegovy, which slows gastric emptying and reduces appetite as part of a clinically supervised weight-management plan. Metronidazole is an antibiotic and antiprotozoal medicine prescribed for infections including bacterial vaginosis, dental abscesses and certain gut infections. Because both can cause gastrointestinal side effects, understanding how they sit together — and when to flag anything to your prescriber — is genuinely useful.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works by activating the GLP-1 receptor, a pathway that reduces appetite, slows the rate at which food leaves the stomach and improves blood-sugar regulation. The semaglutide information page on the NHS sets this out clearly, and the mechanism is well established from the STEP trial programme. Metronidazole targets anaerobic bacteria and certain parasites; it is typically prescribed for a short course of five to seven days.
Where the two medicines share territory is the gut. Nausea, stomach discomfort and loose stools are recognised side effects of metronidazole. They are also among the most commonly reported effects of semaglutide, particularly in the first weeks of treatment or after a dose increase. Running both at the same time does not produce a new or unique interaction, but it can mean that ordinary antibiotic side effects feel more pronounced than they otherwise would.
One practical note: metronidazole's well-known interaction with alcohol is worth keeping front of mind. Drinking alcohol while taking metronidazole can cause a disulfiram-like reaction, flushing, rapid heart rate and intensified nausea. If your GLP-1 treatment has already made you sensitive to nausea, this reaction can feel more distressing. Avoiding alcohol for the duration of the metronidazole course, and for 48 hours after the last tablet, is standard advice from the NHS regardless of whether you are taking semaglutide. It is also worth knowing that some men using semaglutide have questions about sexual health, and our overview of semaglutide and erectile dysfunction covers what the current evidence says on that topic.
One area where semaglutide does require careful thought involves oral medicines taken at the same time. Because semaglutide slows gastric emptying, the absorption of some oral drugs may be altered. The prescribing reference for semaglutide notes this as a theoretical consideration rather than a contraindication for most medicines, but it is a real mechanism.
For metronidazole specifically, no study has measured whether semaglutide changes its pharmacokinetics in a clinically meaningful way. The available evidence does not suggest a problem, and metronidazole is absorbed relatively rapidly even when gastric emptying is slower. What this step is really about is building the habit of flagging all medicines (prescription, over-the-counter and supplements) to your prescriber whenever you start something new alongside semaglutide. That conversation takes less than a minute and rules out the things that do matter.
If you find the gastrointestinal effects of the combination particularly difficult to manage (say, you started metronidazole the week you also moved to a higher semaglutide dose) it is worth talking through timing with whoever prescribed it. Some patients find taking metronidazole with or just after food (where permitted by the prescribing instructions) helps to reduce stomach upset. Always check the patient information leaflet for the antibiotic before adjusting when you take it.
Most people taking metronidazole alongside Wegovy or another semaglutide preparation will experience nothing beyond mild, manageable stomach upset. Knowing which symptoms go beyond the ordinary is the practical skill worth acquiring.
Severe or persistent abdominal pain, particularly if it spreads to the back, should not be attributed to a mild interaction and dismissed. The MHRA has highlighted acute pancreatitis as an infrequent but serious risk with GLP-1 receptor agonists; the January 2026 Drug Safety Update specifically asks patients and clinicians to treat persistent, severe stomach pain as a reason for urgent medical review. Metronidazole is not associated with pancreatitis, so if this symptom appears during your antibiotic course, semaglutide should remain in the frame as the relevant medicine to discuss with a clinician. You can report suspected side effects through the MHRA's Yellow Card scheme, which helps regulators track signals across large numbers of patients.
Signs of a serious allergic reaction (facial swelling, difficulty breathing, a widespread rash) are rare but warrant a 999 call with any medicine. Worsening confusion, unusual mouth tingling or peripheral numbness are recognised, if uncommon, side effects of metronidazole worth mentioning to your GP. If you are at all uncertain about symptoms, the nume support team is available seven days a week for aftercare queries.
The practical close to this topic is simpler than the pharmacology suggests. Tell your prescriber or community pharmacist that you are taking semaglutide whenever a new medicine is prescribed. This is not about panic; it is about giving the clinician reviewing your case the full picture. The frequently asked questions on medication combinations come up regularly enough that it is worth treating this as a standard step rather than an afterthought.
At nume, every repeat order of Wegovy is clinically reviewed by a GPhC-registered prescriber before it is dispensed, the consultation is not a formality. If you are mid-antibiotic course and your next semaglutide pen is due, that review is a natural moment to mention it. People sometimes wonder whether to delay an order around a course of antibiotics or a short holiday; in most cases, a brief antibiotic course does not change your semaglutide schedule, but confirming that with a prescriber is always the right move. Our clinical team and the wider prescribing staff are the people best placed to give you a personalised answer.
If you want to read more about semaglutide's side-effect profile and how the medicine works across the weight-management journey, the semaglutide overview covers the evidence in detail. For a broader look at weight-loss treatment options available in the UK, including how semaglutide compares with other licensed approaches, that page sets out the landscape clearly. You might also find the guide to omeprazole and semaglutide useful if you take a proton pump inhibitor alongside your weekly injection, as it addresses a similar question about concurrent medicines.
If you are not yet on treatment and are considering Wegovy, the starting point is a free clinical consultation. A prescriber will review your full medicine list, including any recurring prescriptions like antibiotics, before recommending anything. Start your free consultation and have those details to hand when you fill in the form.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.